QuidelOrtho Corp. (QDEL)

29.66 +0.86 (+3.00%) USD  |  NASDAQ  |  Dec 11, 16:00
29.61 -0.05 (-0.17%) After-Hours: 07:16
More

QuidelOrtho Research and Development Expense (TTM): 187.70M for Sept. 30, 2025

Research and Development Expense (TTM) Chart

View Research and Development Expense (TTM) for QDEL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (TTM) Range, Past 5 Years

View Research and Development Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (TTM) Benchmarks

View Research and Development Expense (TTM) Benchmarks
Start Trial
Boston Scientific Corp. 1.943B
Intuitive Surgical, Inc. 1.254B
West Pharmaceutical Services, Inc. 71.00M
iRhythm Technologies, Inc. 82.64M
Perspective Therapeutics, Inc. 61.22M